{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-25-011706","form_type":"8-K","ticker":"INBS","cik":"0001725430","company_name":"INTELLIGENT BIO SOLUTIONS INC.","filed_at":"2025-08-07T23:59:59+00:00","discovered_at":"2026-05-14T18:02:44.810333+00:00","generated_at":"2026-05-17T17:56:04.595121+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Intelligent Bio Solutions preliminary Q4 revenue up ~16% sequentially and YoY, driven by cartridge sales","bullets":["Preliminary Q4 FY2025 revenue growth of ~16% sequentially and year-over-year, driven by higher-margin cartridge sales and account growth.","Submitted FDA 510(k) application for opiate test system (codeine) to support planned U.S. market entry.","Completed multilingual system upgrades and launched localized websites to strengthen global adoption across Europe, Middle East, and Latin America.","Full-year FY2025 results and Form 10-K expected to be filed during the week of August 11, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-25-011706","json":"https://secwatch.observer/filing/0001493152-25-011706.json","markdown":"https://secwatch.observer/filing/0001493152-25-011706.md","text":"https://secwatch.observer/filing/0001493152-25-011706.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1725430/000149315225011706/0001493152-25-011706-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1725430/000149315225011706/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T17:56:04.595121+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}